Anya Biopharm (ROCO:7776) ROE % Adjusted to Book Value: 0.37% (As of Dec. 2025)


ROCO:7776 Anya Biopharm Inc ROCO:7776
12 GF Score
Price NT$31.80
! 4 Warning Signs
View Full Analysis

What is Anya Biopharm ROE % Adjusted to Book Value?

Anya Biopharm ROCO:7776 12 ROE % Adjusted to Book Value is 0.37% as of Dec. 2025. GuruFocus rates ROCO:7776 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Anya Biopharm's ROE % for the quarter that ended in Dec. 2025 was 2.14%. Anya Biopharm's PB Ratio for the quarter that ended in Dec. 2025 was 5.83. Anya Biopharm's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 0.37%.

Anya Biopharm ROE % Adjusted to Book Value Related Terms

Anya Biopharm ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Anya Biopharm's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anya Biopharm ROE % Adjusted to Book Value Chart

Anya Biopharm Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 -4.87 -2.52

Anya Biopharm Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial 0.00 0.00 -0.74 -7.34 0.37

ROCO:7776 vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Anya Biopharm's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anya Biopharm ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anya Biopharm's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Anya Biopharm's ROE % Adjusted to Book Value falls into.


ROCO:7776
12GF Score
Anya Biopharm Inc ROCO:7776
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anya Biopharm ROE % Adjusted to Book Value Calculation

Anya Biopharm's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-14.72% / 5.83
=-2.52%

Anya Biopharm's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.14% / 5.83
=0.37%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.37% mean?
Anya Biopharm (ROCO:7776) has a ROE % Adjusted to Book Value of 0.37% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Anya Biopharm and its competitors.
Is Anya Biopharm's ROE % Adjusted to Book Value too high?
Anya Biopharm's current ROE % Adjusted to Book Value is 0.37%. Overall, Anya Biopharm has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Anya Biopharm's ROE % Adjusted to Book Value compare to VRTX and REGN?
Anya Biopharm's ROE % Adjusted to Book Value of 0.37% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Anya Biopharm and its competitors. Anya Biopharm's current ROE % Adjusted to Book Value is 0.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anya Biopharm stock overvalued right now?
Anya Biopharm (ROCO:7776) has a current ROE % Adjusted to Book Value of 0.37%. The current ROE % Adjusted to Book Value is 0.37%. Anya Biopharm's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Anya Biopharm (ROCO:7776), the current ROE % Adjusted to Book Value is 0.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anya Biopharm Business Description

Address No. 3-2, Yuanqu Street, 4th Floor, Nangang, Taipei, TWN, 115603
Anya Biopharm Inc is a pharmaceutical company engaged in the Oral Delivery of Peptides. Its patented technology platform Mira/Je is a flexible solution easy to adapt to a large variety of peptides.
12GF Score

Get the complete analysis for ROCO:7776

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.80
Price